AI/ML Innovations Inc. Announces Proposed Private Placement
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) has announced a proposed non-brokered private placement of up to 6,000,000 units at $0.05 per unit, aiming to raise up to $300,000. Each unit consists of one common share and one warrant, exercisable at $0.10 per share for two years. The company plans to use the net proceeds for working capital requirements. The private placement is subject to regulatory approvals, including from the Canadian Securities Exchange. AI/ML Innovations focuses on artificial intelligence and machine learning in the digital health and wellbeing sector, with investments in Health Gauge, Tech2Heal, and AI Rx Inc.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) ha annunciato un proposta di collocamento privato non intermediaro di fino a 6.000.000 di unità a $0,05 per unità, con l'obiettivo di raccogliere fino a $300.000. Ogni unità è composta da una azione ordinaria e un warrant, esercitabile a $0,10 per azione per due anni. L'azienda prevede di utilizzare i proventi netti per le esigenze di capitale circolante. Il collocamento privato è soggetto ad approvazioni regolamentari, compresa quella della Borsa Canadese. AI/ML Innovations si concentra su intelligenza artificiale e apprendimento automatico nel settore della salute digitale e del benessere, con investimenti in Health Gauge, Tech2Heal e AI Rx Inc.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) ha anunciado una propuesta de colocación privada no intermediada de hasta 6.000.000 de unidades a $0,05 por unidad, con el objetivo de recaudar hasta $300.000. Cada unidad consiste en una acción ordinaria y una opción de compra, ejercitable a $0,10 por acción durante dos años. La empresa planea utilizar los ingresos netos para requisitos de capital de trabajo. La colocación privada está sujeta a las aprobaciones regulatorias, incluida la de la Bolsa de Valores de Canadá. AI/ML Innovations se enfoca en inteligencia artificial y aprendizaje automático en el sector de salud digital y bienestar, con inversiones en Health Gauge, Tech2Heal y AI Rx Inc.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB)는 최대 6,000,000개의 주식을 주식당 $0.05에 발행할 비중개 사모배정을 제안한다고 발표했습니다. 이는 최대 $300,000을 모으기 위한 것입니다. 각 단위는 하나의 보통주와 두 년 동안 주당 $0.10에 행사 가능한 하나의 보증서로 구성됩니다. 회사는 순수익을 운전 자본 요건에 사용하려고 합니다. 사모배정은 캐나다 증권 거래소를 포함한 규제 승인을 받아야 합니다. AI/ML Innovations는 디지털 건강 및 웰빙 분야에서 인공지능과 기계 학습에 중점을 두며, Health Gauge, Tech2Heal, AI Rx Inc.에 투자하고 있습니다.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) a annoncé une proposition de placement privé non intermedié jusqu'à 6.000.000 d'unités à 0,05 $ par unité, visant à lever jusqu'à 300.000 $. Chaque unité est composée d'une action ordinaire et d'un bon de souscription, pouvant être exercé à 0,10 $ par action pendant deux ans. L'entreprise prévoit d'utiliser les produits nets pour ses besoins en fonds de roulement. Le placement privé est soumis à des approbations réglementaires, y compris celle de la Bourse canadienne. AI/ML Innovations se concentre sur l'intelligence artificielle et l'apprentissage automatique dans le secteur de la santé numérique et du bien-être, avec des investissements dans Health Gauge, Tech2Heal et AI Rx Inc.
AI/ML Innovations Inc. (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) hat eine vorgeschlagene nicht vermittelte Privatplatzierung von bis zu 6.000.000 Einheiten zu je $0,05 pro Einheit bekannt gegeben, mit dem Ziel, bis zu $300.000 zu sammeln. Jede Einheit besteht aus einer Stammaktie und einem Warrant, der für zwei Jahre zu einem Preis von $0,10 pro Aktie ausgeübt werden kann. Das Unternehmen plant, die Nettoerlöse für Betriebskapitalbedarf zu verwenden. Die Privatplatzierung unterliegt regulatorischen Genehmigungen, einschließlich der Genehmigung durch die kanadische Börse. AI/ML Innovations konzentriert sich auf künstliche Intelligenz und maschinelles Lernen im digitalen Gesundheits- und Wohlfahrtssektor, mit Investitionen in Health Gauge, Tech2Heal und AI Rx Inc.
- Potential to raise up to $300,000 for working capital
- Warrants provide potential for additional future funding at $0.10 per share
- Strategic focus on AI and ML in digital health sector
- Potential dilution of existing shareholders due to new share issuance
- Low unit price of $0.05 may indicate financial challenges or low market valuation
VICTORIA, BC / ACCESSWIRE / August 9, 2024 / AI/ML Innovations Inc. ("AI/ML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB) is pleased to announce that that it intends to complete a non-brokered private placement offering of up to 6,000,000 units ("Units") at a price of
The Common Shares and Warrants comprising the Units will be subject to a four-month and one day hold period in accordance with the policies of the CSE and applicable securities legislation.
The Company intends to use net proceeds of the Private Placement for working capital requirements.
The Company will pay a finder's fee to qualified finders who assist in selling the Units, in cash or securities or a combination of both, as permitted by CSE policy and applicable securities laws.
The Private Placement is subject to certain conditions including, but not limited to, the receipt of all necessary approvals, including approval from the Canadian Securities Exchange.
For more information about AI/ML Innovations:
For detailed information please see AI/ML's website or the Company's filed documents at www.sedar.com.
For further information, contact: Blake Fallis at (778) 405-0882 or info@aiml-innovations.com.
About AI/ML Innovations Inc. https://aiml-innovations.com/
AI/ML Innovations Inc. has realigned its business operations to capitalize on the burgeoning fields of artificial intelligence (AI) and machine learning (ML), with an initial investment focus on emerging digital health and wellbeing companies that leverage AI, ML, cloud computing and digital platforms to drive transformative healthcare management solutions and precision support delivery across the health continuum. Through strategic partnerships with Health Gauge (
On behalf of the Board of Directors
Tim Daniels, Executive Chairman
THIS PRESS RELEASE DOES NOT CONSTITUTE AN OFFER TO SELL OR THE SOLICITATION OF AN OFFER TO BUY ANY SECURITIES IN ANY JURISDICTION, NOR SHALL THERE BE ANY OFFER, SALE, OR SOLICITATION OF SECURITIES IN ANY STATE IN THE UNITED STATES IN WHICH SUCH OFFER, SALE, OR SOLICITATION WOULD BE UNLAWFUL.
Neither the CSE nor its Regulation Services Provider (as that term is defined in the policies of the CSE)
accepts responsibility for the adequacy or accuracy of this release.
SOURCE: AI/ML Innovations, Inc.
View the original press release on accesswire.com
FAQ
What is the purpose of AI/ML Innovations' (AIMLF) proposed private placement?
How many units is AI/ML Innovations (AIMLF) offering in its August 2024 private placement?
What is the price per unit in AI/ML Innovations' (AIMLF) private placement announced on August 9, 2024?
What does each unit in AI/ML Innovations' (AIMLF) private placement consist of?
